• $34.4M
    Market Cap
  • N/A
    1-Year Change
  • Biotechnology
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: N/A
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

Why Litecoin Soared Over the Weekend

MEI Pharma is pursuing a $100 million private placement to accumulate Litecoin and has appointed Charlie Lee to its board, following a trend of companies adding cryptocurrency to their financial assets amid Bitcoin's recent price surge.

07/21/2025, 3:29 PM • The Motley Fool

Peers

Statistics

More
Day Range
$0.80
$0.87
$0.87
1-Year Range
$0.82
$3.17
$0.87
Latest Close$0.87
Change
+$0.05 (+6.10%)
Volume668,238
Market Cap$34.4M
Shares Outstanding34.0M
P/E (TTM)-0.45
Diluted EPS (TTM)-$2.23
Enterprise Value$26.8M

Information as of 06/03/2026

Company Profile

$34.4M
Market Cap
-$60.8M
Net Income
Sector: Healthcare
Industry: Biotechnology
9920 Pacific Heights Blvd., San Diego, CA, United States, 92121
858 369 7100

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.

Key Executives

  • Justin J. File
  • Robert D. Mass
  • Anne Frese

Current Ownership Distribution

  • Institutions13.5M (39.69%)
  • Insiders9.3M (27.41%)
  • Other7.7M (22.55%)
  • Mutual Funds3.5M (10.34%)